MBB Public Markets’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,781
Closed -$237K 373
2025
Q2
$237K Sell
9,781
-2,317
-19% -$54K 0.02% 434
2025
Q1
$307K Buy
+12,098
New +$317K 0.03% 392
2024
Q4
Sell
-10,620
Closed -$307K 435
2024
Q3
$307K Sell
10,620
-399,394
-97% -$11.7M 0.02% 416
2024
Q2
$11.5M Buy
410,014
+31,710
+8% +$873K 0.23% 79
2024
Q1
$10.5M Sell
378,304
-290,711
-43% -$8.07M 0.64% 33
2023
Q4
$19.3M Buy
+669,015
New +$20.2M 1.19% 29
2022
Q1
Sell
-41,928
Closed -$2.48M 354
2021
Q4
$2.48M Buy
+41,928
New +$2.08M 0.05% 54

Other funds holding PFE

MBB Public Markets's PFE Position: Q3 2025 in Review

MBB Public Markets sold out of Pfizer (PFE) in Q3 2025, closing a stake of 9,781 shares — an estimated $237K sold.

MBB Public Markets first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $19.3M in Q4 2023. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • MBB Public Markets reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 9,781 Pfizer shares in Q3 2025, an estimated $237K.
  • MBB Public Markets first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
  • MBB Public Markets's Pfizer position peaked at $19.3M in Q4 2023.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.